US Stock MarketDetailed Quotes

CSCI COSCIENS Biopharma

Watchlist

4.105
+0.055+1.36%

Trading Sep 11 11:23 ET

12.79MMarket Cap-1528P/E (TTM)

COSCIENS Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-70.85%-1.39M

-189.11%-2.4M

-155.85%-2.73M

-263.43%-1.25M

-85.03%157.95K

-140.04%-813K

-179.61%-828.98K

77.61%4.89M

44.21%762.98K

303.24%1.06M

Net income from continuing operations

-65.35%-1.42M

-391.40%-1.4M

-209.56%-3.55M

-1,048.66%-1.65M

-230.60%-752.99K

-163.44%-860K

-119.60%-284.67K

22.77%3.24M

-114.11%-143.85K

-12.56%576.57K

Operating gains losses

---1.71M

----

Depreciation and amortization

4.14%377K

-0.08%358.46K

4.21%1.47M

5.69%394.57K

14.99%351.93K

0.99%362K

-3.15%358.76K

-4.53%1.41M

0.65%373.31K

-12.10%306.05K

Deferred tax

-101.70%-474K

-428.39%-411.54K

-188.65%-900.61K

-1,123.63%-381.33K

-215.64%-206.28K

-156.03%-235K

-117.34%-77.89K

557.96%1.02M

85.95%-31.16K

--178.38K

Other non cash items

--11K

-12.87%21.77K

0.86%96.59K

-2.24%24.57K

----

-5.56%24.99K

-19.62%95.76K

-13.40%25.13K

-27.99%20.02K

Change In working capital

1,578.05%1.82M

-3.76%-959.03K

106.80%57.21K

-32.69%371.51K

2,716.66%732.7K

-0.51%-123K

25.60%-924.31K

27.43%-840.84K

185.56%551.95K

96.26%-28K

-Change in receivables

-56.74%427K

-1,762.64%-1.11M

390.70%1.79M

5,596.73%448.64K

4.10%412.2K

498.56%987K

94.97%-59.55K

-346.36%-615K

-97.81%7.88K

155.14%395.94K

-Change in inventory

174.44%501K

208.67%392.46K

-10.80%-1.17M

104.90%17.45K

59.10%-153.32K

-54.23%-673K

-422.90%-361.13K

-20.84%-1.06M

42.61%-356.47K

-30.87%-374.83K

-Change in prepaid assets

621.57%368K

-370.95%-119.76K

-680.99%-130.01K

-576.09%-75.05K

-769.52%-80.96K

-50.43%51K

76.53%-25.43K

-74.31%22.38K

175.79%15.76K

-81.85%12.09K

-Change in payables and accrued expense

215.78%565K

74.38%-122.49K

-153.34%-430.75K

-102.21%-19.54K

1,006.35%554.79K

-1,156.51%-488K

-669.26%-478.19K

444.65%807.6K

344.33%884.78K

-132.46%-61.21K

-Change in other working capital

---43K

----

Cash from discontinued investing activities

Operating cash flow

-70.85%-1.39M

-189.11%-2.4M

-155.85%-2.73M

-263.43%-1.25M

-85.03%157.95K

-140.04%-813K

-179.61%-828.98K

77.61%4.89M

44.21%762.98K

303.24%1.06M

Investing cash flow

Cash flow from continuing investing activities

48,025.93%25.88M

-1,711.84%-563.43K

-158.05%-739.28K

-4,641.09%-606.57K

5.30%-47.71K

-34.43%-54K

83.02%-31.1K

53.80%-286.49K

89.03%-12.79K

64.62%-50.38K

Net PPE purchase and sale

-190.74%-157K

-1,711.84%-563.43K

-158.05%-739.28K

-1,056.02%-551.56K

-95.58%-102.72K

-30.56%-54K

78.54%-31.1K

48.11%-286.49K

68.77%-47.71K

64.18%-52.52K

Net business purchase and sale

--26.04M

----

--0

----

Net other investing changes

----

-49.62%2.14K

Cash from discontinued investing activities

Investing cash flow

48,025.93%25.88M

-1,711.84%-563.43K

-158.05%-739.28K

-4,641.09%-606.57K

5.30%-47.71K

-34.43%-54K

83.02%-31.1K

53.80%-286.49K

89.03%-12.79K

64.62%-50.38K

Financing cash flow

Cash flow from continuing financing activities

-80.00%-126K

-15.56%-71.92K

-70.76%-274.05K

-46.56%-84.54K

-47.59%-56.51K

-801.90%-70K

-9.66%-62.24K

33.52%-160.49K

52.34%-57.69K

25.99%-38.29K

Net issuance payments of debt

-80.00%-126K

-12.87%-71.92K

-26.71%-279.26K

-24.15%-77.31K

-44.84%-67.94K

-29.24%-70K

-11.70%-63.72K

16.01%-220.39K

48.55%-62.27K

9.83%-46.91K

Proceeds from stock option exercised by employees

--0

-78.73%12.74K

-93.32%306.4638

32.62%11.43K

--0

412.78%1.48K

185.75%59.9K

54,620.91%4.59K

2,876.51%8.62K

Net other financing activities

----

---7.54K

----

Cash from discontinued financing activities

Financing cash flow

-80.00%-126K

-15.56%-71.92K

-70.76%-274.05K

-46.56%-84.54K

-47.59%-56.51K

-801.90%-70K

-9.66%-62.24K

33.52%-160.49K

52.34%-57.69K

25.99%-38.29K

Net cash flow

Beginning cash position

-62.28%3.51M

-35.90%6.55M

81.59%10.41M

-11.50%8.35M

-3.22%8.54M

32.15%9.3M

63.83%10.21M

36.15%5.73M

62.49%9.44M

50.48%8.82M

Current changes in cash

2,700.32%24.37M

-228.74%-3.03M

-184.28%-3.74M

-379.87%-1.94M

-94.44%53.73K

-147.27%-937K

-215.08%-922.32K

134.87%4.44M

137.61%692.5K

1,330.05%966.68K

Effect of exchange rate changes

-137.22%-67K

----

--180K

----

End cash Position

225.65%27.8M

-62.18%3.51M

-34.49%6.67M

-11.50%8.35M

-3.22%8.54M

32.05%9.29M

66.75%10.18M

62.49%9.44M

Free cash flow

-78.32%-1.55M

-244.16%-2.96M

-175.38%-3.47M

-351.45%-1.8M

-94.49%55.23K

-143.59%-867K

-195.94%-860.08K

109.51%4.6M

90.09%715.26K

802.15%1M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-70.85%-1.39M	-189.11%-2.4M	-155.85%-2.73M	-263.43%-1.25M	-85.03%157.95K	-140.04%-813K	-179.61%-828.98K	77.61%4.89M	44.21%762.98K	303.24%1.06M
Net income from continuing operations	-65.35%-1.42M	-391.40%-1.4M	-209.56%-3.55M	-1,048.66%-1.65M	-230.60%-752.99K	-163.44%-860K	-119.60%-284.67K	22.77%3.24M	-114.11%-143.85K	-12.56%576.57K
Operating gains losses	---1.71M	----	----	----	----	----	----	----	----	----
Depreciation and amortization	4.14%377K	-0.08%358.46K	4.21%1.47M	5.69%394.57K	14.99%351.93K	0.99%362K	-3.15%358.76K	-4.53%1.41M	0.65%373.31K	-12.10%306.05K
Deferred tax	-101.70%-474K	-428.39%-411.54K	-188.65%-900.61K	-1,123.63%-381.33K	-215.64%-206.28K	-156.03%-235K	-117.34%-77.89K	557.96%1.02M	85.95%-31.16K	--178.38K
Other non cash items	--11K	-12.87%21.77K	0.86%96.59K	-2.24%24.57K	----	----	-5.56%24.99K	-19.62%95.76K	-13.40%25.13K	-27.99%20.02K
Change In working capital	1,578.05%1.82M	-3.76%-959.03K	106.80%57.21K	-32.69%371.51K	2,716.66%732.7K	-0.51%-123K	25.60%-924.31K	27.43%-840.84K	185.56%551.95K	96.26%-28K
-Change in receivables	-56.74%427K	-1,762.64%-1.11M	390.70%1.79M	5,596.73%448.64K	4.10%412.2K	498.56%987K	94.97%-59.55K	-346.36%-615K	-97.81%7.88K	155.14%395.94K
-Change in inventory	174.44%501K	208.67%392.46K	-10.80%-1.17M	104.90%17.45K	59.10%-153.32K	-54.23%-673K	-422.90%-361.13K	-20.84%-1.06M	42.61%-356.47K	-30.87%-374.83K
-Change in prepaid assets	621.57%368K	-370.95%-119.76K	-680.99%-130.01K	-576.09%-75.05K	-769.52%-80.96K	-50.43%51K	76.53%-25.43K	-74.31%22.38K	175.79%15.76K	-81.85%12.09K
-Change in payables and accrued expense	215.78%565K	74.38%-122.49K	-153.34%-430.75K	-102.21%-19.54K	1,006.35%554.79K	-1,156.51%-488K	-669.26%-478.19K	444.65%807.6K	344.33%884.78K	-132.46%-61.21K
-Change in other working capital	---43K	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-70.85%-1.39M	-189.11%-2.4M	-155.85%-2.73M	-263.43%-1.25M	-85.03%157.95K	-140.04%-813K	-179.61%-828.98K	77.61%4.89M	44.21%762.98K	303.24%1.06M
Investing cash flow
Cash flow from continuing investing activities	48,025.93%25.88M	-1,711.84%-563.43K	-158.05%-739.28K	-4,641.09%-606.57K	5.30%-47.71K	-34.43%-54K	83.02%-31.1K	53.80%-286.49K	89.03%-12.79K	64.62%-50.38K
Net PPE purchase and sale	-190.74%-157K	-1,711.84%-563.43K	-158.05%-739.28K	-1,056.02%-551.56K	-95.58%-102.72K	-30.56%-54K	78.54%-31.1K	48.11%-286.49K	68.77%-47.71K	64.18%-52.52K
Net business purchase and sale	--26.04M	----	----	----	----	--0	----	----	----	----
Net other investing changes	----	----	----	----	----	----	----	----	----	-49.62%2.14K
Cash from discontinued investing activities
Investing cash flow	48,025.93%25.88M	-1,711.84%-563.43K	-158.05%-739.28K	-4,641.09%-606.57K	5.30%-47.71K	-34.43%-54K	83.02%-31.1K	53.80%-286.49K	89.03%-12.79K	64.62%-50.38K
Financing cash flow
Cash flow from continuing financing activities	-80.00%-126K	-15.56%-71.92K	-70.76%-274.05K	-46.56%-84.54K	-47.59%-56.51K	-801.90%-70K	-9.66%-62.24K	33.52%-160.49K	52.34%-57.69K	25.99%-38.29K
Net issuance payments of debt	-80.00%-126K	-12.87%-71.92K	-26.71%-279.26K	-24.15%-77.31K	-44.84%-67.94K	-29.24%-70K	-11.70%-63.72K	16.01%-220.39K	48.55%-62.27K	9.83%-46.91K
Proceeds from stock option exercised by employees	--0	--0	-78.73%12.74K	-93.32%306.4638	32.62%11.43K	--0	412.78%1.48K	185.75%59.9K	54,620.91%4.59K	2,876.51%8.62K
Net other financing activities	----	----	---7.54K	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-80.00%-126K	-15.56%-71.92K	-70.76%-274.05K	-46.56%-84.54K	-47.59%-56.51K	-801.90%-70K	-9.66%-62.24K	33.52%-160.49K	52.34%-57.69K	25.99%-38.29K
Net cash flow
Beginning cash position	-62.28%3.51M	-35.90%6.55M	81.59%10.41M	-11.50%8.35M	-3.22%8.54M	32.15%9.3M	63.83%10.21M	36.15%5.73M	62.49%9.44M	50.48%8.82M
Current changes in cash	2,700.32%24.37M	-228.74%-3.03M	-184.28%-3.74M	-379.87%-1.94M	-94.44%53.73K	-147.27%-937K	-215.08%-922.32K	134.87%4.44M	137.61%692.5K	1,330.05%966.68K
Effect of exchange rate changes	-137.22%-67K	----	----	----	----	--180K	----	----	----	----
End cash Position	225.65%27.8M	-62.18%3.51M	-34.49%6.67M	-34.49%6.67M	-11.50%8.35M	-3.22%8.54M	32.05%9.29M	66.75%10.18M	66.75%10.18M	62.49%9.44M
Free cash flow	-78.32%-1.55M	-244.16%-2.96M	-175.38%-3.47M	-351.45%-1.8M	-94.49%55.23K	-143.59%-867K	-195.94%-860.08K	109.51%4.6M	90.09%715.26K	802.15%1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall